Cornerstone Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Cornerstone Advisory's LLY Position: Q2 2026 in Review
Cornerstone Advisory increased its Eli Lilly (LLY) stake by 4.6% in Q2 2026, buying an estimated $129K and bringing the position to 2,851 shares worth $3.42M. The position accounts for 0.28% of the portfolio, ranked #59.
Cornerstone Advisory first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cornerstone Advisory held 2,851 shares of Eli Lilly worth $3.42M as of Q2 2026.
- Cornerstone Advisory bought 126 Eli Lilly shares in Q2 2026, an estimated $129K.
- Eli Lilly made up 0.28% of Cornerstone Advisory's portfolio in Q2 2026, its #59 holding.
- Cornerstone Advisory first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
- 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.